Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

IMPORTANCE: Carfilzomib-lenalidomide-dexamethasone therapy yields deep responses in patients with newly diagnosed multiple myeloma (NDMM). It is important to gain an understanding of this combination’s tolerability and impact on minimal residual disease (MRD) negativity because this end point has be...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Oncol
Main Authors: Korde, Neha, Roschewski, Mark, Zingone, Adriana, Kwok, Mary, Manasanch, Elisabet E., Bhutani, Manisha, Tageja, Nishant, Kazandjian, Dickran, Mailankody, Sham, Wu, Peter, Morrison, Candis, Costello, Rene, Zhang, Yong, Burton, Debra, Mulquin, Marcia, Zuchlinski, Diamond, Lamping, Liz, Carpenter, Ashley, Wall, Yvonne, Carter, George, Cunningham, Schuyler C., Gounden, Verena, Sissung, Tristan M., Peer, Cody, Maric, Irina, Calvo, Katherine R., Braylan, Raul, Yuan, Constance, Stetler-Stevenson, Maryalice, Arthur, Diane C., Kong, Katherine A., Weng, Li, Faham, Malek, Lindenberg, Liza, Kurdziel, Karen, Choyke, Peter, Steinberg, Seth M., Figg, William, Landgren, Ola
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6662597/
https://ncbi.nlm.nih.gov/pubmed/26181891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.2010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker